March 2024
Sarepta’s ELEVIDYS Gaining Ground Amidst Anticipation for Expanded Label Approval
ELEVIDYS, Age, Muscular Dystrophy, Duchenne, Sarepta, Labels (device), Child
Actionable Insights Powered by AI
ELEVIDYS, Age, Muscular Dystrophy, Duchenne, Sarepta, Labels (device), Child